Long-Term Effects of Once-Daily Valbenazine in Older and Younger Adults with Tardive Dyskinesia
Sign Up to like & getrecommendations! Published in 2022 at "CNS Spectrums"
DOI: 10.1017/s1092852922000335
Abstract: Abstract Introduction Older patients taking a dopamine receptor blocking agent (eg, first- or second-generation antipsychotic) have an increased risk for tardive dyskinesia (TD), a persistent and potentially disabling movement disorder. Valbenazine, a selective and potent… read more here.
Keywords: valbenazine; long term; tardive dyskinesia; cgi pgic ... See more keywords